Corey Mc Cann Pear Therapeutics, Inc. (PEAR) insider trading activity

PEAR Quotes by TradingView

Corey Mc Cann is President and CEO of Pear Therapeutics, Inc.. Currently has a direct ownership of 8.21 Million shares of PEAR, which is worth approximately $82,108. The most recent transaction as insider was on Jan 20, 2023, when has been sold 34,731 shares (Class A Common Stock) at a price of $1.13 per share, resulting in proceeds of $39,246. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.21M
0% 3M change
0% 12M change
Total Value Held $82,108

Corey McCann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2023
SELL
Open market or private sale
$39,246 $1.13 p/Share
34,731 Reduced 0.42%
8,210,834 Class A Common Stock
Jan 14 2023
BUY
Exercise of conversion of derivative security
-
88,000 Added 1.06%
8,245,565 Common Stock
Dec 03 2021
BUY
Grant, award, or other acquisition
-
8,157,656 Added 50.0%
8,157,656 Class A Common Stock
CM

Corey Mc Cann

President and CEO
Boston, MA

Track Institutional and Insider Activities on PEAR

Follow Pear Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEAR shares.

Notify only if

Insider Trading

Get notified when an Pear Therapeutics, Inc. insider buys or sells PEAR shares.

Notify only if

News

Receive news related to Pear Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PEAR